Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 11
2003 13
2004 15
2005 12
2006 20
2007 22
2008 16
2009 17
2010 18
2011 19
2012 23
2013 35
2014 41
2015 29
2016 34
2017 27
2018 28
2019 29
2020 25
2021 35
2022 43
2023 34
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

493 results

Results by year

Filters applied: . Clear all
Page 1
Colchicine in Patients with Chronic Coronary Disease.
Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, The SHK, Xu XF, Ireland MA, Lenderink T, Latchem D, Hoogslag P, Jerzewski A, Nierop P, Whelan A, Hendriks R, Swart H, Schaap J, Kuijper AFM, van Hessen MWJ, Saklani P, Tan I, Thompson AG, Morton A, Judkins C, Bax WA, Dirksen M, Alings M, Hankey GJ, Budgeon CA, Tijssen JGP, Cornel JH, Thompson PL; LoDoCo2 Trial Investigators. Nidorf SM, et al. Among authors: thompson pl. N Engl J Med. 2020 Nov 5;383(19):1838-1847. doi: 10.1056/NEJMoa2021372. Epub 2020 Aug 31. N Engl J Med. 2020. PMID: 32865380 Clinical Trial.
Low-dose colchicine for secondary prevention of cardiovascular disease.
Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Nidorf SM, et al. Among authors: thompson pl. J Am Coll Cardiol. 2013 Jan 29;61(4):404-410. doi: 10.1016/j.jacc.2012.10.027. Epub 2012 Dec 19. J Am Coll Cardiol. 2013. PMID: 23265346 Free article. Clinical Trial.
Stress-induced β cell early senescence confers protection against type 1 diabetes.
Lee H, Sahin GS, Chen CW, Sonthalia S, Cañas SM, Oktay HZ, Duckworth AT, Brawerman G, Thompson PJ, Hatzoglou M, Eizirik DL, Engin F. Lee H, et al. Among authors: thompson pj. Cell Metab. 2023 Dec 5;35(12):2200-2215.e9. doi: 10.1016/j.cmet.2023.10.014. Epub 2023 Nov 9. Cell Metab. 2023. PMID: 37949065 Free article.
Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation.
Schwarz N, Fernando S, Chen YC, Salagaras T, Rao SR, Liyanage S, Williamson AE, Toledo-Flores D, Dimasi C, Sargeant TJ, Manavis J, Eddy E, Kanellakis P, Thompson PL, Tan JTM, Snel MF, Bursill CA, Nicholls SJ, Peter K, Psaltis PJ. Schwarz N, et al. Among authors: thompson pl. FASEB J. 2023 Apr;37(4):e22846. doi: 10.1096/fj.202201469R. FASEB J. 2023. PMID: 36856983
50 Years of Perception.
Verstraten FAJ, Thompson P, Meese T. Verstraten FAJ, et al. Among authors: thompson p. Perception. 2022 Mar;51(3):153-155. doi: 10.1177/03010066221084480. Epub 2022 Mar 1. Perception. 2022. PMID: 35229670 No abstract available.
Association of Low-Dose Colchicine With Incidence of Knee and Hip Replacements : Exploratory Analyses From a Randomized, Controlled, Double-Blind Trial.
Heijman MWJ, Fiolet ATL, Mosterd A, Tijssen JGP, van den Bemt BJF, Schut A, Eikelboom JW, Thompson PL, van den Ende CHM, Nidorf SM, Popa CD, Cornel JH. Heijman MWJ, et al. Among authors: thompson pl. Ann Intern Med. 2023 Jun;176(6):737-742. doi: 10.7326/M23-0289. Epub 2023 May 30. Ann Intern Med. 2023. PMID: 37247416 Clinical Trial.
Visual aftereffects.
Thompson P, Burr D. Thompson P, et al. Curr Biol. 2009 Jan 13;19(1):R11-4. doi: 10.1016/j.cub.2008.10.014. Curr Biol. 2009. PMID: 19138580 Free article. Review. No abstract available.
493 results